PMV Pharma (NASDAQ:PMVP) just reported results for the first quarter of 2024. PMV Pharma reported earnings per share of -30 ...

Mr Solomon Lew Non-Executive ChairmanNon-Executive Director Mar 2008 Mr Lew has over 50 years experience in the manufacture, wholesale and retailing of textiles, apparel and general merchandise ...

The average one-year price target for PMV Pharmaceuticals (NasdaqGS:PMVP) has been revised to 8.92 / share. This is an increase of 45.83% from the prior estimate of 6.12 dated March 28 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

According to GlobalData’s company profile on PMV Pharmaceuticals, Targeted cancer therapy was a key innovation area identified from patents. PMV Pharmaceuticals's grant share as of February 2024 was ...

IV Values other than above; acceptable for only part of year PMV –0.7 or PMV > 0.7 >15% PMV = predicted mean vote (index of thermal comfort) PPD = predicted percentage (of people) dissatisfied Source: ...

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It’s lead product ...